Follow
Salih HR
Salih HR
Medical Director, KKE Translational Immunology, Department of Internal Medicine, Eberhard Karls University Tübingen
Verified email at med.uni-tuebingen.de
Title
Cited by
Cited by
Year
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia
F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ...
N engl j Med 369, 111-121, 2013
15672013
Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding
HR Salih, HG Rammensee, A Steinle
The Journal of Immunology 169 (8), 4098-4102, 2002
8092002
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
HR Salih, H Antropius, F Gieseke, SZ Lutz, L Kanz, HG Rammensee, ...
Blood 102 (4), 1389-1396, 2003
6892003
Low-dose decitabine versus best supportive care in elderly patients with intermediate-or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final …
M Lübbert, S Suciu, L Baila, BH Rüter, U Platzbecker, A Giagounidis, ...
Journal of clinical oncology 29 (15), 1987-1996, 2011
6382011
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
A Nelde, T Bilich, JS Heitmann, Y Maringer, HR Salih, M Roerden, ...
Nature immunology 22 (1), 74-85, 2021
5852021
Platelet-derived transforming growth factor-β down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity
HG Kopp, T Placke, HR Salih
Cancer research 69 (19), 7775-7783, 2009
5072009
Monitoring of Minimal Residual Disease in NPM1-Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group
J Krönke, RF Schlenk, KO Jensen, F Tschürtz, A Corbacioglu, VI Gaidzik, ...
Journal of Clinical Oncology 29 (19), 2709-2716, 2011
4802011
Natural killer cell–mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate
S Armeanu, M Bitzer, UM Lauer, S Venturelli, A Pathil, M Krusch, S Kaiser, ...
Cancer research 65 (14), 6321-6329, 2005
4442005
Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantation
RF Schlenk, S Kayser, L Bullinger, G Kobbe, J Casper, M Ringhoffer, ...
Blood, The Journal of the American Society of Hematology 124 (23), 3441-3449, 2014
4392014
Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune CellsPlatelet MHC Class I Impairs …
T Placke, M Örgel, M Schaller, G Jung, HG Rammensee, HG Kopp, ...
Cancer research 72 (2), 440-448, 2012
4082012
Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: final results of the …
U Platzbecker, G Avvisati, L Cicconi, C Thiede, F Paoloni, M Vignetti, ...
Journal of Clinical Oncology 35 (6), 605-612, 2017
3902017
Spatial imagery in deductive reasoning: a functional MRI study
M Knauff, T Mulack, J Kassubek, HR Salih, MW Greenlee
Cognitive Brain Research 13 (2), 203-212, 2002
3352002
Soluble MICA in malignant diseases
S Holdenrieder, P Stieber, A Peterfi, D Nagel, A Steinle, HR Salih
International journal of cancer 118 (3), 684-687, 2006
3312006
Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
AM Paczulla, K Rothfelder, S Raffel, M Konantz, J Steinbacher, H Wang, ...
Nature 572 (7768), 254-259, 2019
2972019
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD
RF Schlenk, D Weber, W Fiedler, HR Salih, G Wulf, H Salwender, ...
Blood, The Journal of the American Society of Hematology 133 (8), 840-851, 2019
2882019
More than just tumor destruction: immunomodulation by thermal ablation of cancer
SP Haen, PL Pereira, HR Salih, HG Rammensee, C Gouttefangeas
Clinical and Developmental Immunology 2011, 2011
2722011
Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival
MP Radsak, HR Salih, HG Rammensee, H Schild
The Journal of Immunology 172 (8), 4956-4963, 2004
2712004
Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors
PK Epling-Burnette, F Bai, JS Painter, DE Rollison, HR Salih, M Krusch, ...
Blood, The Journal of the American Society of Hematology 109 (11), 4816-4824, 2007
2602007
High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses
SK Metzelder, T Schroeder, A Finck, S Scholl, M Fey, K Götze, YC Linn, ...
Leukemia 26 (11), 2353-2359, 2012
2542012
Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses
J Hilpert, L Grosse-Hovest, F Grünebach, C Buechele, T Nuebling, ...
The journal of immunology 189 (3), 1360-1371, 2012
2322012
The system can't perform the operation now. Try again later.
Articles 1–20